YENOM NOTICIAS
Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.
Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.
Krystal Biotech's VYJUVEK gene therapy for dystrophic epidermolysis bullosa has already delivered strong commercial traction, generating high revenue and robust gross margins in chronic use. The therapy's specialized manufacturing process,…
Krystal Biotech (KRYS) is drawing fresh attention after news that its VYJUVEK gene therapy for dystrophic epidermolysis bullosa has gained commercial traction, supported by high revenue, strong gross margins, and recurring treatment demand…
Krystal Biotech has produced a very large 5 year share price gain, which naturally puts the focus on whether that move is supported by the business it has built. With the stock now trading around US$324.57, the practical question for you i…
Krystal Biotech, Inc. (NASDAQ:KRYS) has something most biotech companies spend years trying to achieve: a drug that works, is approved, and is already generating meaningful revenue. VYJUVEK, a gene therapy for dystrophic epidermolysis bull…
Shares of Krystal Biotech KRYS have risen 13.4% over the past month compared with the industry's 8.2% growth, fueled by improving investor confidence in the company's commercial performance and its expanding pipeline of genetic medicines.Z…
A month has gone by since the last earnings report for Amgen (AMGN). Shares have added about 8.6% in that time frame, outperforming the S&P 500. But investors have to be wondering, will the recent positive trend continue leading up to its…
Krystal Biotech, Inc. PITTSBURGH, Sept. 03, 2026 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the "Company") (NASDAQ: KRYS) today announced that the Company will participate in the 2026 Cantor Global Healthcare Conference on September 10, 20…
A month has gone by since the last earnings report for Krystal Biotech, Inc. (KRYS). Shares have added about 12% in that time frame, outperforming the S&P 500. But investors have to be wondering, will the recent positive trend continue lea…
[A stack of coins is shown on a blue background with a world map] IURII KRASILNIKOV The put-call ratio for the iShares Russell 2000 ETF (IWM [https://seekingalpha.com/symbol/IWM]) surged to 3.58, with Barchart saying the reading marked the…
Looking for broad exposure to the Small Cap Growth segment of the US equity market? You should consider the State Street SPDR S&P 600 Small Cap Growth ETF (SLYG), a passively managed exchange traded fund launched on September 25, 2000. The…
Krystal Biotech (KRYS) has further room for gains driven by Vyjuvek, its treatment for the rare blistering condition dystrophic epidermolysis bullosa, alongside international launches and growth across its gene therapy pipeline, RBC Capita…
Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. Krystal Biotech stock has delivered a very large 5 year return while recent valuation checks and the latest share price…
[Medical research with pipette and test tube, DNA analysis, biotechnology, genetic science and healthcare] jittawit.21 Big Pharma moved back into the spotlight last week following a Financial Times report that Bristol Myers Squibb (BMY [ht…
Krystal Biotech KRYS reported second-quarter 2026 earnings per share (EPS) of $1.79, which surpassed the Zacks Consensus Estimate of $1.70. The company recorded an EPS of $1.29 in the year-ago quarter. Revenues of $119.2 million rose 24.14…
The S&P 500 Index ($SPX) (SPY) on Monday closed up +1.48%, the Dow Jones Industrial Average ($DOWI) (DIA) closed up +1.32%, and the Nasdaq 100 Index ($IUXX) (QQQ) closed up +1.78%. September E-mini S&P futures (ESU26) rose +1.49%, and Sept…
This article first appeared on GuruFocus. Net Revenue: $119.2 million from global sales of VYJUVEK, a 24% increase from $96 million in Q2 2025. US Net Revenue: $91.6 million for the quarter. Cost of Goods Sold: $6.4 million, down from $7.2…
Bull on Wall Street by Alexander Naumann via Pixabay The S&P 500 Index ($SPX) (SPY) on Monday closed up +1.48%, the Dow Jones Industrial Average ($DOWI) (DIA) closed up +1.32%, and the Nasdaq 100 Index ($IUXX) (QQQ) closed up +1.78%. Septe…
Top-notch biotech stocks TG Therapeutics and Twist Bioscience diverged Monday on mixed earnings reports. Continue Reading
The S&P 500 Index ($SPX) (SPY) today is up +1.18%, the Dow Jones Industrial Average ($DOWI) (DIA) is up +1.081%, and the Nasdaq 100 Index ($IUXX) (QQQ) is up +1.40%. September E-mini S&P futures (ESU26) are up +1.11%, and September E-mini…
As stocks like Eli Lilly, Twilio, Hinge Health and more move ahead of earnings report, pay attention to these chart lines. Continue Reading
The S&P 500 Index ($SPX) (SPY) today is up +0.84%, the Dow Jones Industrial Average ($DOWI) (DIA) is up +1.21%, and the Nasdaq 100 Index ($IUXX) (QQQ) is up +0.47%. September E-mini S&P futures (ESU26) are up +0.90%, and September E-mini N…
The S&P 500 Index ($SPX) (SPY) today is up +1.18%, the Dow Jones Industrial Average ($DOWI) (DIA) is up +1.081%, and the Nasdaq 100 Index ($IUXX) (QQQ) is up +1.40%. September E-mini S&P futures (ESU26) are up +1.11%, and September E-mini…
The S&P 500 Index ($SPX) (SPY) today is up +0.84%, the Dow Jones Industrial Average ($DOWI) (DIA) is up +1.21%, and the Nasdaq 100 Index ($IUXX) (QQQ) is up +0.47%. September E-mini S&P futures (ESU26) are up +0.90%, and September E-mini N…
Krystal Biotech, Inc. (KRYS) came out with quarterly earnings of $1.79 per share, beating the Zacks Consensus Estimate of $1.7 per share. This compares to earnings of $1.29 per share a year ago. These figures are adjusted for non-recurring…
(RTTNews) - Krystal Biotech, Inc. (KRYS) released earnings for its second quarter that Increased, from the same period last year The company's bottom line came in at $54.77 million, or $1.79 per share. This compares with $38.33 million, or…
Krystal Biotech, Inc. $119.2 million in 2Q VYJUVEK global revenue and $965.9 million since launch Multiple clinical data readouts in 2H 2026 On track for VYJUVEK launches in Spain and Italy later this year Strong balance sheet, ending the…
Major earnings expected before the bell on Monday include: * Tyson Foods (TSN [https://seekingalpha.com/symbol/TSN]) * Marriott International (MAR [https://seekingalpha.com/symbol/MAR]) * EchoStar Corporation (ECHO [https://seekingalpha.co…
Use the IBD Stock Checklist to separate the wheat from the chaff in the stock market, specifically in the red-hot biotech sector. Continue Reading
Make better investment decisions with Simply Wall St's easy, visual tools that give you a competitive edge. Krystal Biotech (KRYS) stock drew attention after the company disclosed new information related to KB801, its investigational gene…
Earlier this month, Krystal Biotech, Inc. was moved from the S&P 600 to the S&P 400, joining the S&P 400 Health Care and Biotechnology indices, and also filed a response with the U.S. Patent and Trademark Office that included single-patien…
The market expects Harmony Biosciences Holdings, Inc. (HRMY) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended June 2026. This widely-known consensus outlook is important in a…
The market expects Krystal Biotech, Inc. (KRYS) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended June 2026. This widely-known consensus outlook is important in assessing the…
Krystal Biotech, Inc. PITTSBURGH, July 23, 2026 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the "Company") (NASDAQ: KRYS) announced today that it will report its second quarter 2026 financial results on Monday, August 3, 2026, prior to the…
PITTSBURGH, July 23, 2026 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS) announced today that it will report its second quarter 2026 financial results on Monday, August 3, 2026, prior to the open of U.S. markets.…
Key Points The construction specialist will be a component of the S&P SmallCap 600 index later this week. It replaces the outgoing Krystal Biotech.10 stocks we like better than Tutor Perini › Tutor Perini(NYSE: TPC) has been tapped for inc…
* S&P Dow Jones Indices announced on Monday the latest changes [https://seekingalpha.com/pr/20588716-krystal-biotech-set-to-join-s-and-p-midcap-400-tutor-perini-and-v2x-to-join-s-and-p-smallcap] to its U.S. equity indexes, with merger acti…